Elsevier宣布扩展其旗舰临床决策支持解决方案ClinicalKey AI-动脉网

Elsevier announces expansion to their flagship clinical decision support solution, ClinicalKey AI

CISION 等信源发布 2025-03-04 10:00



可切换为仅中文







New functionality and partnerships make it easier for clinicians to access crucial information at the point of care and log learning credits.

新的功能和合作伙伴关系使临床医生在护理点更容易获取关键信息并记录学分。

NEW YORK

纽约

，

March 3, 2025

2025年3月3日

/PRNewswire/ -- Elsevier, a global leader in health information and data analytics, has announced further enhancements to ClinicalKey AI, the company's leading generative AI-powered clinical decision support solution. The new functionality and integrations with strategic partners aim to transform the way healthcare providers access and utilize actionable insights, enhancing patient care and efficiency directly within the clinician's workflow..

/PRNewswire/ -- 全球健康信息与数据分析领域的领导者爱思唯尔（Elsevier）宣布，对其领先的生成式人工智能临床决策支持解决方案ClinicalKey AI进行进一步增强。新功能及与战略合作伙伴的整合旨在改变医疗服务提供者获取和利用可操作洞察的方式，直接在临床医生的工作流程中提升患者护理质量和效率。

Seamless workflows are crucial for doctors as they enable them to focus more on patient care, reduce time-consuming administrative tasks, and access relevant information efficiently. To serve the needs of busy clinicians, ClinicalKey AI is launching new workflow integrations in the electronic health record (EHR) with Epic.

无缝的工作流程对医生来说至关重要，因为它们能够让医生更加专注于患者的护理，减少耗时的行政任务，并高效获取相关信息。为了满足繁忙临床医生的需求，ClinicalKey AI 正在与 Epic 合作，在电子健康记录（EHR）中推出新的工作流程集成。

[1]

and into the health information technology (HIT) space with iPrescribe by DrFirst, along with a new mobile app available for Apple and Android users.

并通过DrFirst的iPrescribe进入健康信息技术（HIT）领域，同时推出面向苹果和安卓用户的新移动应用。

The new EHR integration will streamline workflows, enabling clinicians to switch between Epic's EHR and ClinicalKey AI without needing to navigate away from patient records. ClinicalKey AI can be found in Connection Hub on Epic Showroom, providing a cohesive experience for clinicians, simplifying the process for accessing essential information at the point of care.

新的EHR集成将简化工作流程，使临床医生能够在Epic的EHR和ClinicalKey AI之间切换，而无需离开患者记录。ClinicalKey AI可以在Epic Showroom的Connection Hub中找到，为临床医生提供了一种连贯的体验，简化了在护理点访问必要信息的过程。

A new ClinicalKey AI mobile app will further boost access, enhancing clinicians' ability to access critical information on the go..

一个新的ClinicalKey AI移动应用程序将进一步提升访问性，增强临床医生随时随地获取关键信息的能力。

Dr.

博士

Barry Wendt

巴里·温德特

, Chief Medical Information Officer at St. Elizabeth Healthcare, a development partner on the Epic EHR integration, said: 'Clinicians are working under increasing pressure, treating multiple patients with complex cases, and simplifying access to vital information is paramount. With ClinicalKey AI's seamless integration with the Epic EHR system, clinicians can easily move between the patient's EHR and the latest evidence-based content, helping them save valuable time when they're treating patients at the point of care.'.

圣伊丽莎白医疗保健公司的首席医疗信息官（St. Elizabeth Healthcare）作为Epic电子健康记录系统集成的开发合作伙伴，表示：“临床医生在日益增加的压力下工作，治疗多名病情复杂的患者，简化获取关键信息的途径至关重要。通过ClinicalKey AI与Epic电子健康记录系统的无缝集成，临床医生可以轻松地在患者的电子健康记录和最新的循证内容之间切换，帮助他们在诊疗时节省宝贵时间。”

The collaboration with DrFirst, which has solutions used by more than 450,000 prescribers, adds the power of ClinicalKey AI decision support to the company's iPrescribe by DrFirst HIT platform. 'Each day, prescribers make the most of every moment to take care of their patients, even while traveling between their homes, various offices, and other facilities,' said .

与DrFirst的合作，其解决方案已被超过450,000名开处方者使用，将ClinicalKey AI决策支持功能引入了该公司的iPrescribe by DrFirst HIT平台。 “每天，开处方者都充分利用每一个时刻来照顾他们的患者，即使在他们往返于家、不同办公室及其他设施之间时，”他表示。

Colin Banas

科林·巴纳斯

, M.D., M.H.A., Chief Medical Officer of DrFirst. 'Making this world-class, evidence-based research tool available within the iPrescribe by DrFirst app gives healthcare providers across all practice sizes and specialties instant access to AI-powered conversational searches of clinical literature—helping them make informed prescribing decisions from anywhere.'.

，医学博士，卫生管理硕士，DrFirst首席医疗官。“在DrFirst的iPrescribe应用程序中提供这一世界级的、基于证据的研究工具，使各规模和各专业的医疗保健提供者能够即时访问由人工智能支持的临床文献对话式搜索——帮助他们随时随地做出明智的处方决策。”

In addition to these new access-enhancing features, ClinicalKey AI will also enable clinicians to earn, track, and claim Continuing Medical Education (CME) and Maintenance of Certification (MOC) credits directly within the platform. Healthcare professionals will be able to earn CME credits through each clinical query and response interaction, seamlessly integrating learning into their daily workflow..

除了这些新增的访问增强功能外，ClinicalKey AI 还将使临床医生能够直接在平台上获取、跟踪和申请继续医学教育 (CME) 以及认证维护 (MOC) 学分。医疗保健专业人员将能够通过每次临床查询和响应互动获得 CME 学分，从而无缝地将学习融入到他们的日常工作流程中。

Furthermore, ClinicalKey AI will support auto-submission of MOC credits to American Boards of eight different specialties (internal medicine, pediatrics, anesthesiology, surgery, pathology, otolaryngology, orthopedic surgery and thoracic surgery). This will make ClinicalKey AI the first AI solution of this kind with this capability..

此外，ClinicalKey AI 将支持自动提交 MOC 学分至八个不同专科的美国委员会（内科、儿科、麻醉科、外科、病理学、耳鼻喉科、骨科手术和胸外科）。这将使 ClinicalKey AI 成为首个具备此功能的同类 AI 解决方案。

Omry Bigger

奥姆里·比格

, President of Clinical Solutions at Elsevier said: 'Healthcare professionals continue to face growing pressures on their time while operating in a fast-moving work environment. Since launching ClinicalKey AI in 2024 as the first Gen-AI solution of its kind, we have continued to expand functionality to support clinicians by streamlining processes, improving access and boosting CME, helping them respond to the challenges they face every day.'.

爱思唯尔临床解决方案总裁表示：“医疗专业人员在快速变化的工作环境中，仍面临着日益增加的时间压力。自2024年推出ClinicalKey AI这一首款同类Gen-AI解决方案以来，我们不断扩展功能，通过简化流程、改善访问和加强继续医学教育（CME）来支持临床医生，帮助他们应对日常面临的挑战。”

ClinicalKey AI is available in over 50 countries and provides answers from a content set that is specifically curated for point of care questions. It enables access to Elsevier titles such as The Lancet, Goldman-Cecil, as well as non-Elsevier titles and a host of other evidence-based sources. Today's announcement builds on the .

ClinicalKey AI 在 50 多个国家/地区可用，提供的答案来自专门为即时护理问题策划的内容集。它能够访问 Elsevier 旗下的《柳叶刀》、《戈德曼-塞西尔》等期刊，以及非 Elsevier 的期刊和众多其他基于证据的来源。今天的公告是建立在这一基础之上的。

expanded partnership

扩展合作伙伴关系

with the American College of Cardiology (ACC) announced earlier this year, which made the ACC's Clinical Practice Guidelines and Expert Consensus Decision Pathways on a range of cardiology topics available on ClinicalKey AI.

与美国心脏病学会 (ACC) 今年早些时候宣布的消息一致，该消息使得ACC在一系列心脏病学主题上的临床实践指南和专家共识决策路径在ClinicalKey AI上可用。

You can learn more about ClinicalKey AI

您可以了解更多关于 ClinicalKey AI 的信息

on our website

在我们的网站上

, and also at the upcoming 2025 HIMSS Conference in

，以及即将于2025年举行的HIMSS会议在

Las Vegas

拉斯维加斯

. Join the Elsevier team at booth 3616 and AI Pavilion Kiosk 121-14 to find out more about ClinicalKey AI. You can also hear from Elsevier spokespeople Dr. Amber Featherstone-Uwague (

加入爱思唯尔团队，前往3616号展位和人工智能展馆121-14号展台，了解更多关于ClinicalKey AI的信息。您还可以听取爱思唯尔发言人Amber Featherstone-Uwague博士的介绍（

3:10 p.m.

下午3点10分

，

March 4

3月4日

) and Dr. Paul 'PJ' Helmuth (

）和保罗·“PJ”·赫尔穆斯博士（

2 p.m.

下午2点

，

March 5

3月5日

) at speaking sessions in the AI Pavillion.

) 在人工智能展馆的演讲环节中。

About Elsevier

关于爱思唯尔

As a global leader in scientific information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making with innovative solutions based on trusted, evidence-based content and advanced AI-enabled digital technologies..

作为科学信息和分析领域的全球领导者，爱思唯尔帮助研究人员和医疗专业人员推动科学发展，并改善健康结果以造福社会。我们通过创新解决方案促进洞察和关键决策，这些解决方案基于值得信赖的、以证据为基础的内容和先进的AI数字技术。

We have supported the work of our research and healthcare communities for more than 140 years. Our 9,500 employees around the world, including 2,500 technologists, are dedicated to supporting researchers, librarians, academic leaders, funders, governments, R&D-intensive companies, doctors, nurses, future healthcare professionals and educators in their critical work.

我们已经支持研究和医疗社区的工作长达140多年。我们全球的9500名员工，其中包括2500名技术专家，致力于支持研究人员、图书管理员、学术领袖、资助者、政府、研发密集型企业、医生、护士、未来的医疗专业人员和教育工作者的重要工作。

Our 2,900 scientific journals and iconic reference books include the foremost titles in their fields, including Cell Press, The Lancet and Gray's Anatomy..

我们的2900份科学期刊和标志性参考书包括其领域中最著名的标题，包括《细胞》出版社、《柳叶刀》和《格氏解剖学》。

Together with the

连同

Elsevier Foundation

爱思唯尔基金会

，

we work in partnership with the communities we serve to advance

我们与所服务的社区合作，共同推进

inclusion and diversity

包容与多样性

in science, research and healthcare in developing countries and around the world.

在科学、研究和医疗保健领域，无论是发展中国家还是全球范围内。

Elsevier is part of

Elsevier 是一部分

RELX

悦刻

, a global provider of information-based analytics and decision tools for professional and business customers. For more information on our work, digital solutions and content, visit

，一家为专业和商业客户提供基于信息的分析和决策工具的全球供应商。欲了解有关我们的工作、数字解决方案和内容的更多信息，请访问

www.elsevier.com

。

About iPrescribe by DrFirst

关于iPrescribe by DrFirst

iPrescribe by DrFirst is the industry-leading e-prescribing solution, trusted by healthcare providers throughout the U.S. It enables safe and efficient prescribing of controlled and non-controlled substances anytime, anywhere. Built for mobility and designed to adapt to any workflow, iPrescribe ensures seamless, compliant prescribing across all practice settings.

iPrescribe by DrFirst 是行业领先的电子处方解决方案，受到全美医疗保健提供商的信赖。它能够随时随地安全高效地开具受控和非受控药物处方。iPrescribe 专为移动性而构建，并设计为适应任何工作流程，确保在各种执业环境中实现无缝且合规的处方开具。

Whether used as a standalone mobile solution or integrated with an EHR, iPrescribe delivers flexibility for in-office and after-hours needs. .

无论作为独立的移动解决方案使用，还是与电子健康记录（EHR）集成，iPrescribe都能灵活满足办公室内和下班后的需求。

DrFirst solutions help 100 million patients a year and are used by more than 450,000 prescribers, 71,000 pharmacies, 270 EHRs and health information systems, and over 2,000 hospitals in the U.S. To learn more, visit iPrescribe.com and DrFirst.com.

DrFirst 的解决方案每年帮助 1 亿名患者，被超过 45 万名开药者、7.1 万家药店、270 家电子健康记录和健康信息系统以及美国 2000 多家医院使用。如需了解更多信息，请访问 iPrescribe.com 和 DrFirst.com。

Logo -

标志 -

https://mma.prnewswire.com/media/2628519/5194789/Elsevier_Logo.jpg

SOURCE Elsevier

来源 Elsevier

WANT YOUR COMPANY'S NEWS

想要贵公司的新闻吗

FEATURED ON PRNEWSWIRE.COM?

荣登PRNEWSWIRE.COM？

440k+

44万+